Neurological and psychiatric safety of tafenoquine in Plasmodium vivax relapse prevention: a review (Q90310182)
Jump to navigation
Jump to search
scientific article published on 14 March 2020
Language | Label | Description | Also known as |
---|---|---|---|
English | Neurological and psychiatric safety of tafenoquine in Plasmodium vivax relapse prevention: a review |
scientific article published on 14 March 2020 |
Statements
Neurological and psychiatric safety of tafenoquine in Plasmodium vivax relapse prevention: a review (English)
Stephan Duparc
Stephan Chalon
Scott Miller
Naomi Richardson
14 March 2020
3 references
28 April 2021
3 October 2022
3 references
28 April 2021
3 October 2022
2 references
28 April 2021
3 October 2022
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference